Literature DB >> 30895877

Safety and Putative Benefits of Tracheostomy Tube Placement in Patients on Extracorporeal Membrane Oxygenation: A Single-Center Experience.

Jatinder Grewal1,2, Anna-Liisa Sutt2,3, George Cornmell4, Kiran Shekar2,3,4,5, John Fraser2,3,4.   

Abstract

PURPOSE: Patients supported with extracorporeal membrane oxygenation (ECMO) have been reported to have increased sedation requirements. Tracheostomies are performed in intensive care to facilitate longer term mechanical ventilation, reduce sedation, improve patient comfort, secretion clearance, and ability to speak and swallow. We aimed to investigate the safety of tracheostomy (TT) placement on ECMO, its impact on fluid intake, and the use of sedative, analgesic, and vasoactive drugs.
METHODS: Prospective data were collated for all ECMO patients over a 5.5-year period. Data included the cumulative dose of sedatives and analgesics, fluid balance, inotrope and vasopressor requirements, and number of packed red cell (PRC) units transfused. Data were analyzed to determine the differences in the aforementioned between 5 days pre-TT and post-TT insertion.
RESULTS: Thirty-one (22.1%) of 140 patients underwent TT while on ECMO in the study period. Inotrope and vasopressor use was significantly less in the post-TT period compared to pre-TT dose (P value = .01). This was in the setting of Sequential Organ Failure Assessment scores the day before TT placement being significantly greater than those on days 2, 3, and 4. There was a trend toward reduction in analgesic usage in the post-TT period. No major complications of TT were reported. There was no significant difference (P value = .46) in the amount of PRC used post-TT.
CONCLUSIONS: These data indicate that TT may result in a reduction in vasopressor and inotropic requirement. Data do not suggest increased major bleeding with placement of TT in patients on ECMO. The potential risk and benefits of inserting a TT in ECMO patients need further validation in prospective clinical studies.

Entities:  

Keywords:  ECMO; inotrope; sedation; tracheostomy; vasopressor

Mesh:

Substances:

Year:  2019        PMID: 30895877     DOI: 10.1177/0885066619837939

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  4 in total

1.  Tracheostomy while on Extracorporeal Membrane Oxygenation: A Comparison of Percutaneous and Open Procedures.

Authors:  Ismael A Salas De Armas; Kha Dinh; Bindu Akkanti; Pushan Jani; Reshma Hussain; Lisa Janowiak; Kayla Kutilek; Manish K Patel; Mehmet H Akay; Rahat Hussain; Jayeshkumar Patel; Chandni Patel; Yafen Liang; John Zaki; Biswajit Kar; Igor D Gregoric
Journal:  J Extra Corpor Technol       Date:  2020-12

Review 2.  Protocol-driven daily optimisation of venovenous extracorporeal membrane oxygenation blood flows: an alternate paradigm?

Authors:  Kiran Shekar; Hergen Buscher; Daniel Brodie
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

3.  Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series.

Authors:  Hussam Elmelliti; Dnyaneshwar Pandurang Mutkule; Muhammad Imran; Nabil Abdelhamid Shallik; Ali Ait Hssain; Ahmed Labib Shehatta
Journal:  J Cardiothorac Vasc Anesth       Date:  2022-09-20       Impact factor: 2.894

4.  Tracheostomy management in patients with severe acute respiratory distress syndrome receiving extracorporeal membrane oxygenation: an International Multicenter Retrospective Study.

Authors:  Matthieu Schmidt; Christoph Fisser; Gennaro Martucci; Darryl Abrams; Thomas Frapard; Konstantin Popugaev; Antonio Arcadipane; Bianca Bromberger; Giovanni Lino; Alexis Serra; Sacha Rozencwajg; Matthias Lubnow; Sergey Petrikov; Thomas Mueller; Alain Combes; Tài Pham; Daniel Brodie
Journal:  Crit Care       Date:  2021-07-07       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.